RJF vs RPID · rev $15.91B vs rev $16.1M
RJF (RJF) versus Rapid Micro Biosystems Inc (RPID) — a side-by-side from cached financials, not a winner call.
RJF (RJF) common stock.
Rapid Micro Biosystems Inc (RPID) is a medical devices company listed on NASDAQ.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
Latest reported RPID revenue for 2026-06-30 was $16.1M. Net income was -$27.2M. RPID currently screens at market cap $85.7M.
RJF currently screens at market cap $0. RPID currently screens at market cap $85.7M.
Not investment advice. Open the RJF and RPID stock pages for the full models.
Not investment advice.